The arteries that supply the penis are very small and may be more prone to atherosclerosis than larger vessels. This means that the penis may be the first area in a man’s body to suffer from a reduction in blood flow and so signal cardiovascular disease.
Statin therapy for secondary prevention of coronary heart disease: an update (part 2)
The metabolic syndrome: myth or clinically useful marker?
The European perspective
Leave nothing to chance
A case of severe aortic stenosis
Cardiovascular risk management series: 2 – Using guidelines as a framework for cardiovascular risk management
Reducing the impact of vascular disease: the proposed Vascular Risk Programme for risk assessment and management
Measurement of baseline total cholesterol: new data from The Health Improvement Network (THIN) database
Ambulatory ECG monitoring in primary care
Cardiac arrhythmia affects more than 700,000 people in England and is consistently in the top ten reasons for hospital admission, consuming significant accident and emergency time and bed days.1 In the general population, arrhythmias are normally quite minor, silent, and typically benign. Symptoms may affect the patient enough to be both disruptive and distressful. In […]
The HYVET study: answering the question of whether or not to treat hypertension in the very elderly
Lipid lowering as part of secondary prevention of CVD: doing it the nice way
All patients with cardiovascular disease (CVD) should be offered drug treatment to reduce their cholesterol levels without waiting for the management of modifiable risk factors, recommends the latest guidance on lipid modification from the National Institute for Health and Clinical Excellence (NICE). The much-anticipated guideline finally puts to bed the ‘5 and 3’ or ‘4 and 2’ debate over cholesterol levels for primary and secondary prevention. In this article, we review what the guidance says about lipid lowering in secondary prevention.
